NCT03967873

Brief Summary

prospective multicenter observational study. Parents whose children meet the inclusion criteria complete a questionnaire assessing the child's follow-up, the management of the current asthma attack, and the treatment provided at home. The main objective is to calculate the prevalence of placement of short-acting bronchodilators. The secondary objectives are to describe the factors associated with their implementation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
350

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Oct 2018

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 9, 2018

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

May 28, 2019

Completed
2 days until next milestone

First Posted

Study publicly available on registry

May 30, 2019

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2020

Completed
Last Updated

August 24, 2020

Status Verified

August 1, 2020

Enrollment Period

1.7 years

First QC Date

May 28, 2019

Last Update Submit

August 20, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • prevalence of short-acting bronchodilator induction in children attending emergency room for asthma attack

    1 hour

Eligibility Criteria

Age2 Years - 15 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

children between 2 and 15 years old in Quimper or Brest emergency department for asthma attacks whose parents agree to fill in a questionnaire about their pre-hospital attitude.

You may qualify if:

  • child over 2 years emergency room consultant for asthma attack
  • child whose parents did not express their opposition to participate and completed the non-objection form
  • child consultant in pediatric emergencies of Quimper and Brest

You may not qualify if:

  • child whose age is not between 2 and 15 years old
  • cough equivalent of asthma
  • history of cardiac or pulmonary pathology or prematurity
  • refusal to participate

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

CHRU de Brest

Brest, 29609, France

Location

Ch Quimper

Quimper, 29000, France

Location

MeSH Terms

Conditions

Treatment Adherence and Compliance

Condition Hierarchy (Ancestors)

Health BehaviorBehavior

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 28, 2019

First Posted

May 30, 2019

Study Start

October 9, 2018

Primary Completion

June 30, 2020

Study Completion

June 30, 2020

Last Updated

August 24, 2020

Record last verified: 2020-08

Locations